This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Futures Drop Amid Weak Private Payrolls, Q2 Earnings Solid
by Zacks Equity Research
U.S. stock futures drop in today's pre-market after the benchmark S&P 500 posted its 44th closing high yesterday.
CVS Health (CVS) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 16.91% and 3.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
A Hint Towards a Taper - But No Tantrum
by David Borun
Stocks were little changed during a week that could have been quite eventful.
Is a Beat in the Cards for CVS Health (CVS) in Q2 Earnings?
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital approach to administer vaccines across the nation is expected to have strongly contributed to its Q2 performance within retail segment.
CVS Health (CVS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $82.87 in the latest trading session, marking a -0.48% move from the prior day.
The Zacks Analyst Blog Highlights: BHP Group, Booking Holdings, CVS Health, Chipotle Mexican Grill and Exelon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BHP Group, Booking Holdings, CVS Health, Chipotle Mexican Grill and Exelon
Q2 Earnings Scorecard and Research Reports for BHP, Booking & CVS Health
by Sheraz Mian
Today's Research Daily features a real-time scorecard and new research reports on BHP Group (BHP), Booking Holdings (BKNG), CVS Health (CVS) and others.
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $81.80, marking a +1.4% move from the previous day.
CVS Health (CVS) Stock Moves -1.28%: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $80.67, moving -1.28% from the previous trading session.
How Investors Can Grab Better Returns for Retail and Wholesale Using the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CVS Health (CVS) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $81.66, marking a -0.2% move from the previous day.
The Zacks Analyst Blog Highlights: Shopify, Lowe's, CVS Health, Moderna and The Bank of New York Mellon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Shopify, Lowe's, CVS Health, Moderna and The Bank of New York Mellon
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
CVS Health (CVS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $81.34, moving +0.2% from the previous trading session.
Top Research Reports for Shopify, Lowe's & CVS Health
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Shopify (SHOP), Lowe's Companies (LOW), and CVS Health (CVS).
Bear of the Day: Rite Aid (RAD)
by David Bartosiak
The competition is fierce and earnings are moving in the wrong direction
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Pandemic Woes
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from growing demand for digital healthcare support. Industry players CVS, WBA and HLF are set to gain the most. However, Amazon's entry threat disrupts this uptrend.
Can CVS Health (CVS) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $82.22, marking a -1.46% move from the previous day.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $84.08 in the latest trading session, marking a +0.37% move from the prior day.
CVS Health (CVS) Stock Moves -0.1%: What You Should Know
by Zacks Equity Research
In the latest trading session, CVS Health (CVS) closed at $83.73, marking a -0.1% move from the previous day.
Factors Likely to Influence Rite Aid's (RAD) Q1 Earnings
by Zacks Equity Research
Strength in PBM and Elixir and expanded omnichannel services are likely to have aided Rite Aid (RAD) in Q1. However, rising pandemic costs and low testing demand are likely to have been worrisome.
CVS Health (CVS) Digital Tools Gain Steam Amid COVID-19 Crisis
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital strategy is more relevant in the current environment as people are increasingly using technology while staying indoors.
The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health